Cookies on this website

We use cookies to ensure that we give you the best experience on our website. If you click 'Accept all cookies' we'll assume that you are happy to receive all cookies and you won't see this message again. If you click 'Reject all non-essential cookies' only necessary cookies providing core functionality such as security, network management, and accessibility will be enabled. Click 'Find out more' for information on how to change your cookie settings.

DOI

10.1097/qad.0000000000002573

Type

Journal

AIDS (London, England)

Publication Date

07/2020

Volume

34

Pages

1435 - 1436

Addresses

Department of Infectious Diseases and Applied Immunology, IMSUT Hospital of The Institute of Medical Science, The University of Tokyo.

Keywords

Humans, Pneumonia, Viral, Coronavirus Infections, HIV Infections, Oxazines, Piperazines, Pyridones, Ritonavir, Adenine, Heterocyclic Compounds, 3-Ring, Alanine, Lamivudine, Dideoxynucleosides, Drug Combinations, Antiviral Agents, Anti-HIV Agents, Adult, Middle Aged, Female, Male, Pandemics, Lopinavir, Tenofovir, Emtricitabine, Transgender Persons, Heterocyclic Compounds, 4 or More Rings, Betacoronavirus, COVID-19, SARS-CoV-2, COVID-19 Drug Treatment